ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...
Measuring treatment success in Sjögren's disease requires more than tracking systemic disease activity alone. Fatigue, pain, ...
The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.
Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...
Patient-reported fatigue prior to cancer treatment could be used as a biomarker for identifying which individuals will develop serious or fatal adverse events.A retrospective analysis showed patients ...
Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...
Using Music as a Tool for Distress Reduction During Cancer Chemotherapy Treatment Future work should aim to improve patient adherence to remote patient-reported outcome and activity data collection ...
A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...
When doctors and insurers want to evaluate a patient’s health status, they typically use objective and broad measures, such as laboratory and vital sign measures like blood pressure or hemoglobin A1c, ...
Invitation-only working summit convenes FDA, CMS, and industry leaders April 10 in Charlotte, North Carolina. This call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback